Almost 2,300 people have already received the fourth dose of the Covid vaccine in Lanzarote

This new campaign started on September 26 and is currently aimed at people over 60 years of age.

October 10 2022 (20:36 WEST)
Updated in October 10 2022 (20:37 WEST)
Vaccination in Lanzarote
Vaccination in Lanzarote

The Lanzarote Health Area, attached to the Ministry of Health of the Government of the Canary Islands, has already administered a total of 2,287 doses of the new vaccines against the coronavirus, adapted to the Omicron variants, with which the second booster dose is being applied. The process began on September 26, with the population over 80 years of age and people residing in senior centers and disability care centers, and since October 5 it has been opened to all those over 60.

Of the total doses administered, 738 have been inoculated to people over 80 years of age, while the rest corresponds to residents in centers and to the population over 60 years of age. 

To receive this fourth dose (or second booster dose), people over 60 years of age must make an appointment through the app or website of MiCitaPrevia of the SCS or by calling 012 (928 301 012).

It should be remembered that the booster dose can only be received if at least five months have passed since the last dose received against covid-19.

In the case of having presented a recent coronavirus infection, they must wait at least three months from the infection to receive this booster dose, always within the interval of five months between doses. In the case of people between 60 and 79 years of age, they must wait five months from the infection.

 

Second booster doses

From the Ministry of Health they emphasize that the new multivalent vaccines, used as booster doses, "can enhance and expand the immune response and therefore the protection against all clinical manifestations".

They also remind that "it is necessary to reach high vaccination coverages in the most vulnerable groups, regardless of their infection history, since booster doses are associated with greater protection against the ómicron variant and some of its subvariants".

Therefore, they insist that "it is necessary to maintain the recommendations to start primary vaccination if it has not yet been done and complete the vaccination schedule even if the disease has passed".

Most read